Skip to main content
Fig. 6 | BMC Pharmacology and Toxicology

Fig. 6

From: Generic-reference and generic-generic bioequivalence of forty-two, randomly-selected, on-market generic products of fourteen immediate-release oral drugs

Fig. 6

Average bioequivalence among randomly-selected, reference-bioequivalent generic products of 14 immediate-release, non-combinational, oral drugs. Three generic products (Ga, Gb, Gc) were compared. Data represent generic/generic geometric mean ratios and unadjusted 90% confidence intervals. The shaded area indicates the area of bioequivalence (80.00%–125.00%). a Evaluation of area-under-the-concentration-time curve to time of maximum concentration of reference product, calculated for each subject (AUCReftmax). b Evaluation of area-under-the-concentration-time curve truncated to 72 h (AUC72). Only 2 drugs (amlodipine and fluconazole) in this study have terminal half-life >72 h

Back to article page